Related Experiment Video
Updated: Mar 5, 2026

09:41
Performing and Processing FNA of Anterior Fat Pad for Amyloid
Published on: October 30, 2010
56.4K
Primary Localized Cutaneous Amyloidosis: A Systematic Treatment Review
Till Weidner1, Tanja Illing2, Peter Elsner2
1Department of Dermatology, University Hospital Jena, Erfurter Straße 35, Jena, 07743, Germany. till.weidner@med.uni-jena.de.
American Journal of Clinical Dermatology
|March 26, 2017
Summary
Treatments for primary localized cutaneous amyloidosis (PLCA) are diverse but lack evidence. Further research, including randomized controlled trials, is needed for effective PLCA therapies.
Area of Science:
- Dermatology
- Pathology
Background:
- Primary localized cutaneous amyloidosis (PLCA) involves amyloid protein deposition in the skin.
- Subtypes include lichen, macular, and nodular amyloidosis.
Purpose of the Study:
- To review current treatment options for primary localized cutaneous amyloidosis (PLCA).
Main Methods:
- Systematic review of English and German articles from 1985 to 2016.
- Literature search conducted using the PubMed database.
Main Results:
- Treatment reports primarily consist of case studies and small series.
- Various treatments were documented, including retinoids, corticosteroids, and laser therapy.
- Clinical trials were scarce and lacked control groups.
Conclusions:
- No definitive treatment recommendations for PLCA can be made from current literature.
- High-quality, evidence-based therapies require randomized controlled trials.
Related Concept Videos
Skin Cancer
6.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.4K
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K

